Anti-Parkinson Drugs Industry Demand, In-Depth Analysis With Booming Trends And Forecast 2031 - GlaxoSmithKline plc, Pfizer, Merck

The global anti-Parkinsons drugs market size is expected to grow from $8.86 billion in 2021 to $9.56 billion in 2022 at a compound annual growth rate (CAGR) of 7.9%. The global anti-Parkinson drugs market size is expected to reach $12.25 billion in 2026 at a CAGR of 6.4%.

The Business Research Company offers the Anti-Parkinson Drugs Global Market Report 2022 in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market's historic and forecast growth, and highlights important trends and strategies that players in the market can adopt.

Directly Purchase The Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3462

The anti-Parkinson drugs market consists of sales of drugs used for treating Parkinson's disease (PD), generated by the establishments that manufacture these drugs. Parkinson's disease is a neurodegenerative disorder that affects predominately dopaminergic neurons in a specific area of the brain named substantia nigra and disturbs the movement of the body. People suffering from PD may experience tremor, bradykinesia, limb rigidity, gait, and balance problems.

Some key anti-Parkinsons drugs market players are Decathlon S.A, Amer Sports Corporation, Callaway Golf Company, Nike, Inc., Adidas AG, Puma SE, Globeride, Inc., Newell Brands Inc., YONEX Co., Ltd., and Mizuno Corporation.

The countries covered in the global anti-Parkinsons drugs market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.

The regions covered in the global anti-Parkinsons drugs market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Anti-Parkinson Drugs Market Segmentation:
By Drugs Class
1. Levodopa/Carbidopa
2. Dopamine Receptor Agonists
3. Monoamine Oxidase Type B (MAO-B) Inhibitors
4. Catechol-O-Methyltransferase (COMT)-inhibitors
5. Anticholinergics

By Route of Administration
1. Oral
2. Injection
3. Transdermal

By Distribution Channel
1. Hospital Pharmacies
2. Retailer Pharmacies
3. Online Pharmacies

See More On The Report At -
https://www.thebusinessresearchcompany.com/report/anti-parkinson-drugs-global-market-report

The Report's Table Of Contents includes
1. Executive Summary
2. Anti-Parkinson Drugs Market Characteristics
3. Anti-Parkinson Drugs Market Trends And Strategies
4. Impact Of COVID-19 On Anti-Parkinson Drugs
5. Anti-Parkinson Drugs Market Size And Growth
………
28. Key Mergers And Acquisitions In The Anti-Parkinson Drugs Market
29. Anti-Parkinson Drugs Market Future Outlook And Potential Analysis
30. Appendix

This report covers the trends and market dynamics of the sporting and anti-parkinson drugs market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Request For A Sample Of This Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3462&type=smp

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Check out our blog: http://blog.tbrc.info/

And follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

About Us:
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. It has published over 3000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

This release was published on openPR.